Tim Townes, PhD

University of Alabama at Birmingham · company speakers →

Dr. Townes will describe the development of nine modified Cas9 proteins that can be complexed with a single guide RNA (sgRNA) and a single stranded oligodeoxynucleotide (ssODN) correction template, nucleoporated into primary sickle patient or humanized sickle mouse hematopoietic stem cells and efficiently correct the sickle mutation.

Is this you? Claim this profile →